CytomX Therapeutics Inc — 貸借対照表 (NASDAQ:CTMX) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 358.66 M339.41 M260.89 M201.79 M120.53 M151.57 M 負債合計 308.86 M250.03 M346.64 M249.24 M120.99 M52.56 M 純資産合計 49.8 M89.38 M-85.75 M-47.45 M-456 K99.01 M 負債および純資産合計 358.66 M339.41 M260.89 M201.79 M120.53 M151.57 M 有利子負債合計 —————— 純負債 ——————

ニュース

Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?

3 Best Stocks to Buy Today, 3/23/2026, According to Top Analysts - TipRanks.com

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

CytomX Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:CTMX) 2026-03-17

CytomX launches $250M public offering to fund drug development

Micron and Intel among market cap stock movers on Monday

CytomX: The Probody Mask Just Slipped, And Investors Like What They See (Upgrade) (CTMX)

Micron, Intel among market cap stock movers on Monday

【決算速報】サイトメックス・セラピューティクス、売上高は予想を下回り、利益は予想を下回る結果に

CytomX Therapeutics Inc earnings missed by $0.24, revenue fell short of estimates

Oppenheimer、治験データを受けてCytomX株の目標株価を引き上げ

Oppenheimer raises CytomX stock price target on trial data